Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Elemer Piros's Stock Ratings
LUCID CAPITAL MARKETS Analyst
Elemer Piros is an analyst at LUCID CAPITAL MARKETS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/16/2025
Updated: Dec 16, 2025
Overall Average Return
16.9%
Smart Score
Overall Average Return Percentile
72nd
Number of Ratings
145
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/09/2025 | XOMA | Buy Now | XOMA Royalty | $25.49 | 198.16% | → $76 | Initiates | → Buy | Get Alert | |
| 10/06/2025 | SAVA | Buy Now | Cassava Sciences | $2.82 | 183.75% | → $8 | Initiates | → Buy | Get Alert | |
| 07/15/2025 | BTAI | Buy Now | BioXcel Therapeutics | $1.84 | 3486.96% | $66 → $66 | Reiterates | Buy → Buy | Get Alert | |
| 03/19/2025 | BTAI | Buy Now | BioXcel Therapeutics | $1.84 | 3432.61% | → $65 | Initiates | → Buy | Get Alert | |
| 12/12/2024 | FBLG | Buy Now | FibroBiologics | $0.26 | 4572.9% | → $12 | Initiates | → Buy | Get Alert | |
| 12/06/2024 | THAR | Buy Now | Tharimmune | $2.38 | 614.29% | → $17 | Initiates | → Buy | Get Alert | |
| 10/29/2024 | QNCX | Buy Now | Quince Therapeutics | $3.75 | 193.33% | → $11 | Initiates | → Buy | Get Alert | |
| 10/11/2024 | MNPR | Buy Now | Monopar Therapeutics | $75.12 | -33.44% | → $50 | Initiates | → Buy | Get Alert | |
| 09/30/2024 | MIRA | Buy Now | Mira Pharmaceuticals | $1.45 | 1072.41% | → $17 | Initiates | → Buy | Get Alert | |
| 08/19/2024 | ATHA | Buy Now | Athira Pharma | $3.87 | 468.48% | → $22 | Initiates | → Buy | Get Alert | |
| 08/08/2024 | SAVA | Buy Now | Cassava Sciences | $2.82 | 3695.13% | $107 → $107 | Reiterates | Buy → Buy | Get Alert | |
| 07/02/2024 | CGTX | Buy Now | Cognition Therapeutics | $1.65 | 748.48% | $14 → $14 | Reiterates | Buy → Buy | Get Alert | |
| 07/02/2024 | ANVS | Buy Now | Annovis Bio | $3.80 | 1663.16% | $67 → $67 | Reiterates | Buy → Buy | Get Alert | |
| 06/21/2024 | ANRO | Buy Now | Alto Neuroscience | $18.00 | 138.89% | → $43 | Initiates | → Buy | Get Alert | |
| 06/13/2024 | COYA | Buy Now | Coya Therapeutics | $5.96 | 202.01% | → $18 | Initiates | → Buy | Get Alert | |
| 09/14/2023 | HOTH | Buy Now | Hoth Therapeutics | $1.09 | 588.07% | $12 → $7.5 | Maintains | Buy | Get Alert | |
| 08/23/2023 | HOTH | Buy Now | Hoth Therapeutics | $1.09 | 1184.4% | → $14 | Assumes | → Buy | Get Alert | |
| 08/09/2023 | ATAI | Buy Now | ATAI Life Sciences | $4.11 | 264.96% | $15 → $15 | Reiterates | Buy → Buy | Get Alert | |
| 08/09/2023 | COYA | Buy Now | Coya Therapeutics | $5.96 | 369.8% | → $28 | Reiterates | Buy → Buy | Get Alert | |
| 08/04/2023 | MNMD | Buy Now | Mind Medicine | $12.19 | 72.27% | → $21 | Reiterates | Buy → Buy | Get Alert | |
| 08/03/2023 | CMPS | Buy Now | Compass Pathways | $6.60 | 475.76% | → $38 | Reiterates | → Buy | Get Alert | |
| 07/18/2023 | COYA | Buy Now | Coya Therapeutics | $5.96 | 369.8% | → $28 | Reiterates | Buy → Buy | Get Alert | |
| 07/13/2023 | CMPS | Buy Now | Compass Pathways | $6.60 | 475.76% | → $38 | Reiterates | Buy → Buy | Get Alert | |
| 07/10/2023 | KTTA | Buy Now | Pasithea Therapeutics | $1.16 | 72.41% | → $2 | Reiterates | Buy → Buy | Get Alert | |
| 06/30/2023 | UNCY | Buy Now | Unicycive Therapeutics | $5.96 | -16.07% | → $5 | Reiterates | Buy → Buy | Get Alert | |
| 06/20/2023 | ATAI | Buy Now | ATAI Life Sciences | $4.11 | 264.96% | $15 → $15 | Reiterates | Buy → Buy | Get Alert | |
| 06/20/2023 | MNMD | Buy Now | Mind Medicine | $12.19 | 72.27% | → $21 | Reiterates | Buy → Buy | Get Alert | |
| 06/20/2023 | CYBN | Buy Now | Cybin | — | — | → $3 | Reiterates | Buy → Buy | Get Alert | |
| 06/20/2023 | CMPS | Buy Now | Compass Pathways | $6.60 | 475.76% | → $38 | Reiterates | Buy → Buy | Get Alert | |
| 06/20/2023 | CLNN | Buy Now | Clene | $6.36 | 57.23% | $13 → $10 | Maintains | Buy | Get Alert | |
| 06/07/2023 | COYA | Buy Now | Coya Therapeutics | $5.96 | 369.8% | → $28 | Reiterates | Buy → Buy | Get Alert | |
| 06/01/2023 | KTTA | Buy Now | Pasithea Therapeutics | $1.16 | 72.41% | → $2 | Assumes | → Buy | Get Alert | |
| 06/01/2023 | HOTH | Buy Now | Hoth Therapeutics | $1.09 | 1184.4% | → $14 | Assumes | → Buy | Get Alert | |
| 05/30/2023 | CMPS | Buy Now | Compass Pathways | $6.60 | 475.76% | → $38 | Reiterates | Buy → Buy | Get Alert | |
| 05/18/2023 | MNMD | Buy Now | Mind Medicine | $12.19 | 72.27% | → $21 | Reiterates | Buy → Buy | Get Alert | |
| 05/17/2023 | UNCY | Buy Now | Unicycive Therapeutics | $5.96 | -16.07% | → $5 | Reiterates | Buy → Buy | Get Alert | |
| 05/16/2023 | COYA | Buy Now | Coya Therapeutics | $5.96 | 369.8% | → $28 | Reiterates | Buy → Buy | Get Alert | |
| 05/16/2023 | OPT | Buy Now | Opthea | — | — | → $23 | Reiterates | Buy → Buy | Get Alert | |
| 05/11/2023 | CMPS | Buy Now | Compass Pathways | $6.60 | 475.76% | → $38 | Reiterates | Buy → Buy | Get Alert | |
| 05/10/2023 | COYA | Buy Now | Coya Therapeutics | $5.96 | 369.8% | → $28 | Reiterates | Buy → Buy | Get Alert | |
| 05/05/2023 | MNMD | Buy Now | Mind Medicine | $12.19 | 72.27% | → $21 | Reiterates | → Buy | Get Alert | |
| 05/03/2023 | COYA | Buy Now | Coya Therapeutics | $5.96 | 369.8% | → $28 | Initiates | → Buy | Get Alert | |
| 04/17/2023 | OPT | Buy Now | Opthea | — | — | → $23 | Initiates | → Buy | Get Alert | |
| 04/14/2023 | MNMD | Buy Now | Mind Medicine | $12.19 | 72.27% | → $21 | Reiterates | → Buy | Get Alert | |
| 04/12/2023 | CMPS | Buy Now | Compass Pathways | $6.60 | 475.76% | → $38 | Reiterates | → Buy | Get Alert | |
| 03/31/2023 | ATAI | Buy Now | ATAI Life Sciences | $4.11 | 264.96% | $15 → $15 | Reiterates | → Buy | Get Alert | |
| 03/31/2023 | UNCY | Buy Now | Unicycive Therapeutics | $5.96 | 302.85% | → $24 | Reiterates | → Buy | Get Alert | |
| 03/28/2023 | MNPR | Buy Now | Monopar Therapeutics | $75.12 | -77.37% | $24 → $17 | Maintains | Buy | Get Alert | |
| 03/27/2023 | ATAI | Buy Now | ATAI Life Sciences | $4.11 | 264.96% | $15 → $15 | Reiterates | → Buy | Get Alert | |
| 03/24/2023 | MNPR | Buy Now | Monopar Therapeutics | $75.12 | -68.05% | → $24 | Reiterates | → Buy | Get Alert | |
| 03/23/2023 | CLNN | Buy Now | Clene | $6.36 | 104.4% | → $13 | Reiterates | → Buy | Get Alert | |
| 03/13/2023 | CLNN | Buy Now | Clene | $6.36 | 104.4% | → $13 | Reiterates | → Buy | Get Alert | |
| 03/10/2023 | MNMD | Buy Now | Mind Medicine | $12.19 | 72.27% | → $21 | Reiterates | → Buy | Get Alert | |
| 03/09/2023 | CLNN | Buy Now | Clene | $6.36 | 104.4% | → $13 | Reiterates | → Buy | Get Alert | |
| 03/09/2023 | UNCY | Buy Now | Unicycive Therapeutics | $5.96 | -16.07% | → $5 | Initiates | → Buy | Get Alert | |
| 03/08/2023 | CLNN | Buy Now | Clene | $6.36 | 104.4% | → $13 | Initiates | → Buy | Get Alert | |
| 03/07/2023 | ATAI | Buy Now | ATAI Life Sciences | $4.11 | 264.96% | $15 → $15 | Reiterates | → Buy | Get Alert | |
| 03/02/2023 | GHRS | Buy Now | GH Research | $12.45 | 165.06% | → $33 | Reiterates | → Buy | Get Alert | |
| 02/28/2023 | CMPS | Buy Now | Compass Pathways | $6.60 | 475.76% | → $38 | Reiterates | → Buy | Get Alert | |
| 02/14/2023 | CYBN | Buy Now | Cybin | — | — | → $3 | Reiterates | → Buy | Get Alert | |
| 02/14/2023 | REUN | Buy Now | Reunion Neuroscience | — | — | → $11 | Reiterates | → Buy | Get Alert | |
| 02/14/2023 | MNPR | Buy Now | Monopar Therapeutics | $75.12 | -68.05% | → $24 | Reiterates | → Buy | Get Alert | |
| 01/23/2023 | MNPR | Buy Now | Monopar Therapeutics | $75.12 | -68.05% | → $24 | Initiates | → Buy | Get Alert | |
| 01/06/2023 | ATAI | Buy Now | ATAI Life Sciences | $4.11 | 264.96% | $23 → $15 | Maintains | Buy | Get Alert | |
| 12/16/2022 | ATAI | Buy Now | ATAI Life Sciences | $4.11 | 459.61% | → $23 | Initiates | → Buy | Get Alert | |
| 12/16/2022 | GHRS | Buy Now | GH Research | $12.45 | 165.06% | → $33 | Initiates | → Buy | Get Alert | |
| 12/16/2022 | CMPS | Buy Now | Compass Pathways | $6.60 | 475.76% | → $38 | Initiates | → Buy | Get Alert | |
| 12/16/2022 | MNMD | Buy Now | Mind Medicine | $12.19 | 72.27% | → $21 | Initiates | → Buy | Get Alert | |
| 12/16/2022 | CYBN | Buy Now | Cybin | — | — | → $3 | Initiates | → Buy | Get Alert | |
| 12/16/2022 | REUN | Buy Now | Reunion Neuroscience | — | — | → $11 | Initiates | → Buy | Get Alert | |
| 06/16/2022 | GHRS | Buy Now | GH Research | $12.45 | 430.12% | → $66 | Initiates | → Buy | Get Alert | |
| 05/04/2022 | MNMD | Buy Now | Mind Medicine | $12.19 | -42.58% | → $7 | Initiates | → Buy | Get Alert | |
| 04/14/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 62.93% | → $40 | Downgrade | Neutral → Sell | Get Alert | |
| 01/04/2022 | UBX | Buy Now | Unity Biotechnology | — | — | → $4 | Upgrade | Neutral → Buy | Get Alert | |
| 12/01/2021 | BRTX | Buy Now | BioRestorative Therapies | $1.11 | 3233.33% | → $37 | Initiates | → Buy | Get Alert | |
| 11/29/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 62.93% | $46 → $40 | Downgrade | Buy → Neutral | Get Alert | |
| 11/11/2021 | ATAI | Buy Now | ATAI Life Sciences | $4.11 | 678.59% | → $32 | Initiates | → Buy | Get Alert | |
| 09/10/2021 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 87.37% | $80 → $46 | Maintains | Buy | Get Alert | |
| 08/09/2021 | UNCY | Buy Now | Unicycive Therapeutics | $5.96 | 126.6% | → $13.5 | Initiates | → Buy | Get Alert | |
| 06/30/2021 | DMAC | Buy Now | DiaMedica Therapeutics | $9.37 | 241.52% | $38 → $32 | Maintains | Buy | Get Alert | |
| 05/06/2021 | GBT | Buy Now | Global Blood Therapeutics | — | — | $128 → $124 | Maintains | Buy | Get Alert | |
| 04/28/2021 | CLXPF | Buy Now | Cybin | — | — | → $10 | Initiates | → Buy | Get Alert | |
| 04/01/2021 | CMPS | Buy Now | Compass Pathways | $6.60 | 1233.33% | → $88 | Initiates | → Buy | Get Alert | |
| 02/17/2021 | DMAC | Buy Now | DiaMedica Therapeutics | $9.37 | 305.55% | → $38 | Initiates | → Buy | Get Alert | |
| 02/03/2021 | CLNN | Buy Now | Clene | $6.36 | 277.36% | → $24 | Initiates | → Buy | Get Alert | |
| 01/28/2021 | MNPR | Buy Now | Monopar Therapeutics | $75.12 | -34.77% | → $49 | Initiates | → Buy | Get Alert | |
| 12/23/2020 | ARCT | Buy Now | Arcturus Therapeutics | $7.11 | 982.98% | → $77 | Downgrade | Buy → Sell | Get Alert | |
| 12/15/2020 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 197.35% | $50 → $73 | Maintains | Buy | Get Alert | |
| 11/06/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | $131 → $128 | Maintains | Buy | Get Alert | |
| 10/12/2020 | DRRX | Buy Now | Durect | — | — | → $7 | Initiates | → Buy | Get Alert | |
| 09/17/2020 | CWBR | Buy Now | CohBar | — | — | → $8 | Initiates | → Buy | Get Alert | |
| 09/08/2020 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 08/17/2020 | UBX | Buy Now | Unity Biotechnology | — | — | $35 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 07/30/2020 | ARCT | Buy Now | Arcturus Therapeutics | $7.11 | 982.98% | → $77 | Reinstates | → Buy | Get Alert | |
| 07/28/2020 | UBX | Buy Now | Unity Biotechnology | — | — | → $35 | Initiates | → Buy | Get Alert | |
| 07/20/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | → $129 | Initiates | → Buy | Get Alert | |
| 07/20/2020 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 103.67% | → $50 | Initiates | → Buy | Get Alert | |
| 05/28/2020 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | $21 → $24 | Maintains | Overweight | Get Alert | |
| 05/12/2020 | PTE | Buy Now | PolarityTE | — | — | $9 → $3 | Maintains | Overweight | Get Alert | |
| 11/19/2019 | ARWR | Buy Now | Arrowhead Pharma | $68.21 | -26.7% | $24 → $50 | Maintains | Neutral | Get Alert | |
| 11/11/2019 | PTE | Buy Now | PolarityTE | — | — | $50 → $13 | Maintains | Overweight | Get Alert | |
| 10/22/2019 | ALDX | Buy Now | Aldeyra Therapeutics | $3.46 | 853.76% | → $33 | Assumes | → Overweight | Get Alert | |
| 08/08/2019 | ICPT | Buy Now | Intercept Pharma | — | — | $191 → $186 | Reiterates | → Overweight | Get Alert | |
| 07/11/2019 | DVAX | Buy Now | Dynavax Technologies | $10.85 | — | — | Upgrade | Neutral → Overweight | Get Alert | |
| 06/28/2019 | ARWR | Buy Now | Arrowhead Pharma | $68.21 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 05/06/2019 | OMER | Buy Now | Omeros | $9.15 | 184.15% | → $26 | Initiates | → Overweight | Get Alert | |
| 02/28/2019 | ICPT | Buy Now | Intercept Pharma | — | — | $170 → $191 | Reiterates | Overweight → Overweight | Get Alert | |
| 02/25/2019 | ONCE | Buy Now | Spark Therapeutics | — | — | $80 → $114.5 | Downgrade | Overweight → Neutral | Get Alert | |
| 12/17/2018 | ARWR | Buy Now | Arrowhead Pharma | $68.21 | 141.9% | $145 → $165 | Maintains | Overweight | Get Alert | |
| 11/07/2018 | PTI | Buy Now | Proteostasis Therapeutics | — | — | → $21 | Initiates | → Overweight | Get Alert | |
| 10/01/2018 | ICPT | Buy Now | Intercept Pharma | — | — | → $170 | Assumes | → Overweight | Get Alert | |
| 09/21/2018 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | → $21 | Initiates | → Overweight | Get Alert | |
| 09/14/2018 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 281.36% | $32 → $36 | Maintains | Overweight | Get Alert | |
| 09/11/2018 | KRYS | Buy Now | Krystal Biotech | $242.98 | -88.48% | → $28 | Initiates | → Overweight | Get Alert | |
| 08/09/2018 | SBBP | Buy Now | Strongbridge Biopharma | — | — | $14 → $17 | Maintains | Overweight | Get Alert | |
| 08/08/2018 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 115.89% | $52 → $53 | Maintains | Overweight | Get Alert | |
| 06/28/2018 | GBT | Buy Now | Global Blood Therapeutics | — | — | $69 → $96 | Maintains | Overweight | Get Alert | |
| 06/13/2018 | COOL | Buy Now | Corner Growth Acquisition | — | — | $70 → $65 | Maintains | Overweight | Get Alert | |
| 05/24/2018 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 111.81% | → $52 | Initiates | → Overweight | Get Alert | |
| 05/09/2018 | ARWR | Buy Now | Arrowhead Pharma | $68.21 | — | — | Upgrade | Neutral → Overweight | Get Alert | |
| 05/01/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | $100 → $103 | Maintains | Overweight | Get Alert | |
| 02/28/2018 | GBT | Buy Now | Global Blood Therapeutics | — | — | $61 → $72 | Maintains | Overweight | Get Alert | |
| 02/15/2018 | COOL | Buy Now | Corner Growth Acquisition | — | — | → $70 | Initiates | → Overweight | Get Alert | |
| 02/12/2018 | ARWR | Buy Now | Arrowhead Pharma | $68.21 | -92.67% | $2 → $5 | Maintains | Neutral | Get Alert | |
| 12/06/2017 | SBBP | Buy Now | Strongbridge Biopharma | — | — | → $14 | Initiates | → Overweight | Get Alert | |
| 11/10/2017 | DVAX | Buy Now | Dynavax Technologies | $10.85 | 130.41% | $24 → $25 | Maintains | Overweight | Get Alert | |
| 11/02/2017 | ICPT | Buy Now | Intercept Pharma | — | — | — | Upgrade | Underweight → Neutral | Get Alert | |
| 10/25/2017 | ALDX | Buy Now | Aldeyra Therapeutics | $3.46 | 535.84% | → $22 | Initiates | → Overweight | Get Alert | |
| 10/12/2017 | ABEO | Buy Now | Abeona Therapeutics | $5.09 | 567.87% | $21 → $34 | Maintains | Overweight | Get Alert | |
| 10/02/2017 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | — | Upgrade | Neutral → Overweight | Get Alert | |
| 09/22/2017 | VSAR | Buy Now | Versartis | — | — | $34 → $14 | Maintains | Overweight | Get Alert | |
| 09/15/2017 | DVAX | Buy Now | Dynavax Technologies | $10.85 | 121.2% | → $24 | Initiates | → Overweight | Get Alert | |
| 07/20/2017 | SBPH | Buy Now | Spring Bank | — | — | → $29 | Initiates | → Overweight | Get Alert | |
| 07/12/2017 | OCUL | Buy Now | Ocular Therapeutix | $14.17 | 48.2% | $35 → $21 | Maintains | Overweight | Get Alert | |
| 05/11/2017 | OMER | Buy Now | Omeros | $9.15 | 63.93% | $21 → $15 | Downgrade | Buy → Neutral | Get Alert | |
| 05/05/2017 | VSAR | Buy Now | Versartis | — | — | → $34 | Initiates | → Overweight | Get Alert | |
| 03/30/2017 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 154.24% | $17 → $24 | Reiterates | → Overweight | Get Alert | |
| 03/16/2017 | GBT | Buy Now | Global Blood Therapeutics | — | — | → $61 | Initiates | → Overweight | Get Alert | |
| 02/10/2017 | OCUL | Buy Now | Ocular Therapeutix | $14.17 | 147% | → $35 | Initiates | → Overweight | Get Alert | |
| 12/21/2016 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | → $28 | Initiates | → Overweight | Get Alert | |
| 11/01/2016 | GBT | Buy Now | Global Blood Therapeutics | — | — | — | Initiates | → Buy | Get Alert | |
| 10/05/2016 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 80.08% | → $17 | Initiates | → Buy | Get Alert | |
| 10/04/2016 | CRBP | Buy Now | Corbus Pharmaceuticals | $9.44 | 80.08% | → $17 | Initiates | → Buy | Get Alert | |
| 06/02/2016 | ONCE | Buy Now | Spark Therapeutics | — | — | → $100 | Initiates | → Buy | Get Alert | |
| 06/02/2016 | OMER | Buy Now | Omeros | $9.15 | 129.51% | → $21 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved